RxDoctor Payments Data

Richard Carpenter

Family · Cardiff By The Sea, CANPI 1740359967

Payments from drug & device makers

$4,475in general payments, 2019–2025

Across 202 payments — averaging $22.15 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Scilex Pharmaceuticals Inc.$1K
  • Collegium Pharmaceutical, Inc.$930
  • AbbVie$380
  • Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$321
  • Pfizer$306
  • Vanda Pharmaceuticals Inc.$278
  • plus $1K from 12 others

What the payments were for

  • Food & beverage$4,475100%
  • Gifts$00%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$4,475 in reported general payments places this provider in the 90th percentile of 10,634 family providers in California.

See all family providers in California

Most prescribed under Part D

DrugClaimsCost to plans & patients
Xtampza ErOxycodone Myristate62$79,671
OxycontinOxycodone Hcl71$51,223
RelistorMethylnaltrexone Bromide17$43,586
Nucynta ErTapentadol Hcl30$37,068
ZtlidoLidocaine40$34,885
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen911$33,855
NucyntaTapentadol Hcl28$25,227
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen489$19,033
Buprenorphine-NaloxoneBuprenorphine Hcl/Naloxone Hcl77$11,281
Oxycodone Hcl568$10,032
Lidocaine77$8,705
ButransBuprenorphine11$6,886
MovantikNaloxegol Oxalate16$6,528
Buprenorphine14$5,864
SavellaMilnacipran Hcl12$5,613

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Collegium Pharmaceutical, Inc.Xtampza Er, Nucynta Er, Nucynta$930$141,966120 claims
Salix Pharmaceuticals, A Division Of Bausch Health US, LLCRelistor$321$43,58617 claims
Scilex Pharmaceuticals Inc.Ztlido$1,236$34,88540 claims
AbbVieSavella$380$5,61312 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 10,634 family providers in California.

Other family in Cardiff By The Sea

See the full list for California

Where these figures come from

Is this you, or does something look wrong? →